These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10669362)

  • 1. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection.
    Kas-Deelen AM; de Maar EF; Harmsen MC; Driessen C; van Son WJ; The TH
    J Infect Dis; 2000 Feb; 181(2):721-4. PubMed ID: 10669362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.
    Kas-Deelen AM; Harmsen MC; De Maar EF; Oost-Kort WW; Tervaert JW; Van Der Meer J; Van Son WJ; The TH
    Kidney Int; 2000 Dec; 58(6):2533-42. PubMed ID: 11115088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease.
    Gerna G; Zavattoni M; Baldanti F; Furione M; Chezzi L; Revello MG; Percivalle E
    J Med Virol; 1998 May; 55(1):64-74. PubMed ID: 9580888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
    Kim CK; Song JH; Kim SM; Peck KR; Oh W; Huh W; Kim YG; Kim SJ; Joh JW; Lee NY; Park CG; Hwang ES; Cha CY; Oh HY
    Transplantation; 2003 Jun; 75(12):2151-5. PubMed ID: 12829929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Câmara NO; Granato CF
    Int Immunopharmacol; 2009 Jan; 9(1):26-31. PubMed ID: 18824137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Sagedal S; Hartmann A; Rollag H
    Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A; Serrano R; Gimeno A; de Juan J; Merino E; Jiménez del Cerro L; Olivares J
    Nefrologia; 2007; 27(2):202-8. PubMed ID: 17564566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long-term graft function.
    Li YT; Emery VC; Surah S; Jarmulowicz M; Sweny P; Kidd IM; Griffiths PD; Clark DA
    J Med Virol; 2010 Jan; 82(1):85-93. PubMed ID: 19950242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus persistence in macrophages and endothelial cells.
    Fish KN; Stenglein SG; Ibanez C; Nelson JA
    Scand J Infect Dis Suppl; 1995; 99():34-40. PubMed ID: 8668941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Lengerke C; Ljubicic T; Meisner C; Loeffler J; Sinzger C; Einsele H; Hebart H
    Bone Marrow Transplant; 2006 Jul; 38(1):53-60. PubMed ID: 16788683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.
    Percivalle E; Revello MG; Vago L; Morini F; Gerna G
    J Clin Invest; 1993 Aug; 92(2):663-70. PubMed ID: 8394385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.
    Helantera I; Koskinen P; Tornroth T; Loginov R; Gronhagen-Riska C; Lautenschlager I
    Transplantation; 2003 Jun; 75(11):1858-64. PubMed ID: 12811246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.